The patient burden of screening mammography recall

Journal of Women's Health

Volumn 23, Issue , 2014, Pages S11-S19

  Alcusky, Matthew ^a   Philpotts, Liane ^b   Bonafede, MacHaon ^c   Clarke, Janice ^a   Skoufalos, Alexandria ^a  

^a JEFFERSON COLLEGE OF POPULATION HEALTH   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IBM WATSON HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DIAGNOSTIC IMAGING; ECHOMAMMOGRAPHY; FALSE POSITIVE RESULT; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; IMAGE GUIDED BIOPSY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIODIAGNOSIS; REPEAT PROCEDURE; SCREENING TEST; BIOPSY; BREAST TUMOR; COST OF ILLNESS; EARLY DIAGNOSIS; ECONOMICS; EVALUATION STUDY; INSURANCE; LABORATORY DIAGNOSIS; MASS SCREENING; MIDDLE AGED; PSYCHOLOGICAL ASPECT; SOCIOECONOMICS; STATISTICS; TIME; UTILIZATION REVIEW;

ADULT; AGED; BIOPSY; BREAST NEOPLASMS; COST OF ILLNESS; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HEALTH CARE COSTS; HUMANS; INSURANCE COVERAGE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 84907465827     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2014.1511     Document Type: Article

References (37)

1. DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin 2014;64:52-62
2. Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: Update 2003. CA Cancer J Clin 2003;53:141-169
3. American College of Obstetricians-Gynecologists. Practice bulletin no. 122: Breast cancer screening. Obstet Gynecol 2011;118:372-382
4. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009;151:716-726, W-236
5. Gøtzsche PC, Jørgensen KJ. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2013;6: CD001877
6. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: An independent review. Lancet 2012;380:1778-1786
7. Helvie MA, Chang JT, Hendrick RE, Banerjee M. Reduction in late-stage breast cancer incidence in the mammography era: Implications for overdiagnosis of invasive cancer. Cancer. 2014;120:2649-2656
8. Biller-Andorno N, Jüni P. Abolishing mammography screening programs? A view from the Swiss Medical Board. N Engl J Med 2014;370:1965-1967
9. Pace LE, He Y, Keating NL. Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer 2013;119: 2518-2523
10. Canadian Task Force on Preventive Health Care. Recommendations on screening for breast cancer in averagerisk women aged 40-74 years. CMAJ 2011;183:1991-2001
11. Forrest APM. Breast cancer screening: Report to the Health Ministers of England, Wales, Scotland and Northern Ireland by a working group. London: HM Stationery Office, 1987
12. Hubbard RA, Kerlikowske K, Flowers CI, Yankaskas BC, Zhu W, Miglioretti DL. Cumulative probability of false positive recall or biopsy recommendation after 10 years of screening mammography: A cohort study. Ann Intern Med. 2011;155:481-492
13. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998;338:1089-1096
14. Secker-Walker RH, Vacek PM, Hooper GJ, Plante DA, Detsky AS. Screening for breast cancer: Time, travel, and outof-pocket expenses. J Natl Cancer Inst 1999;91:702-708
15. Tosteson AN, Fryback DG, Hammond CS, et al. Consequences of false positive screening mammograms. JAMA Intern Med 2014;174:954-961
16. Bonafede MM, Miller JD, Lenhart GM, Nelson J, Fajardo LL. Health insurer burden of patient recall following breast cancer screening mammography: Potential impact of 3D mammography. Value Health 2014;17:A82
17. Madan J, Rawdin A, Stevenson M, Tappenden P. A rapidresponse economic evaluation of the UK NHS Cancer Reform Strategy breast cancer screening program extension via a plausible bounds approach. Value Health 2010;13: 215-221
18. LeMasters T, Sambamoorthi U. A national study of out-ofpocket expenditures for mammography screening. J Womens Health (Larchmt) 2011;20:1775-1783
19. Makuc DM, Breen N, Meissner HI, Vernon SW, Cohen A. Financial barriers to mammography: Who pays out-ofpocket? J Womens Health (Larchmt) 2007;16:349-360
20. McAlearney AS, Reeves KW, Tatum C, Paskett ED. Cost as a barrier to screening mammography among underserved women. Ethn Health 2007;12:189-203
21. Bolejko A, Zackrisson S, Hagell P, Wann-Hansson C. A roller coaster of emotions and sense-coping with the perceived psychosocial consequences of a false positive screening mammography. J Clin Nurs 2014;23:2053-2062
22. Hafslund B, Nortvedt MW. Mammography screening from the perspective of quality of life: A review of the literature. Scand J Caring Sci 2009;23:539-548
23. Brodersen J, Siersma VD. Long-Term psychosocial consequences of false positive screening mammography. Ann Fam Med 2013;11: 106-115
24. Woolley C, Philips Z, Whynes DK, et al.; TOMBOLA Group. United Kingdom cervical cancer screening and the costs of time and travel. Int J Technol Assess Health Care 2007;23:232-239
25. Yabroff KR, Guy GP Jr, Ekwueme DU, et al. Annual patient time costs associated with medical care among cancer survivors in the United States. Med Care 2014;52: 594-601
26. Claxton G, Rae M, Panchal N, et al. Health benefits in 2013: Moderate premium increases in employer-sponsored plans. Health Aff (Millwood) 2013;32:1667-1676
27. Fronstin P. Findings from the 2012 EBRI/MGA Consumer Engagement in Health Care Survey. EBRI Issue Brief 2012;(379):1-27
28. Smith-Bindman R, Chu PW, Miglioretti DL, et al. Comparison of screening mammography in the United States and the United kingdom. JAMA 2003;290:2129-2137
29. O'Donoghue C, Eklund M, Ozanne EM, Esserman LJ. Aggregate cost of mammography screening in the United States: Comparison of current practice and advocated guidelines. Ann Intern Med 2014;160:145
30. Rosenberg RD, Yankaskas BC, Abraham LA, et al. Performance benchmarks for screening mammography. Radiology 2006;241:55-66. Erratum in: Radiology 2014; 271:620
31. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA 201425;311:2499-2507
32. Skaane P, Bandos AI, Gullien R, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology 2013;267:47-56
33. Ciatto S, Houssami N, Bernardi D, et al. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): A prospective comparison study. Lancet Oncol 2013;14583-589
34. Rose SL, TidwellAL, Bujnoch LJ, Kushwaha AC,Nordmann AS, Sexton R Jr. Implementation of breast tomosynthesis in a routine screening practice: An observational study. AJR Am J Roentgenol 2013;200:1401-1408
35. Haas BM, Kalra V, Geisel J, Raghu M, Durand M, Philpotts LE. Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. Radiology 2013;269:694-700
36. Destounis S, Arieno A, Morgan R. Initial experience with combination Digital breast tomosynthesis plus full field digital mammography or full field digital mammography alone in the screening environment. J Clin Imaging Sci 2014;4:9
37. Pérez-Stable EJ, Afable-Munsuz A, Kaplan CP, et al. Factors influencing time to diagnosis after abnormal mammography in Diverse women. J Womens Health (Larchmt) 2013;22: 159-166